Co‐mutation of TP53 and PIK3CA is a primary mediator of anti‐apoptotic protein inhibition of MOMP that lead to a more aggressive phenotype with a worse prognosis in breast cancer.56 This evidence concerns the gene TP53 and breast carcinoma.